Supplementary Figure S1 from Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis Article Swipe

PDF

Naval Daver , Jayastu Senapati , Hagop M. Kantarjian , Bofei Wang , Patrick K. Reville , Sanam Loghavi , Musa Yılmaz , Courtney D. DiNardo , Tapan M. Kadia , Mhd Yousuf Yassouf , Abhishek Maiti , Sankalp Arora , Guillermo Montalban‐Bravo , Guilin Tang , Gautam Borthakur , Koji Sasaki , Naveen Pemmaraju , Joie Alvarez , Graciela M. Nogueras‐González , Jing Ning , Ghayas C. Issa , Marina Konopleva , Michael Andreeff , Farhad Ravandi , Guillermo Garcia‐Manero , Hussein A. Abbas ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.29313332

Study Treatment Schema

Related Topics

Acute Myeloid Leukemia

Concepts

Venetoclax Azacitidine Myeloid leukemia Medicine Refractory (planetary science) Leukemia Myeloid Internal medicine Oncology Chemistry Biology Gene expression Chronic lymphocytic leukemia Biochemistry Gene DNA methylation Astrobiology

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.29313332
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4411285670

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411285670

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.29313332

Digital Object Identifier
Title: Supplementary Figure S1 from Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-06-13

Full publication date if available
Authors: Naval Daver, Jayastu Senapati, Hagop M. Kantarjian, Bofei Wang, Patrick K. Reville, Sanam Loghavi, Musa Yılmaz, Courtney D. DiNardo, Tapan M. Kadia, Mhd Yousuf Yassouf, Abhishek Maiti, Sankalp Arora, Guillermo Montalban‐Bravo, Guilin Tang, Gautam Borthakur, Koji Sasaki, Naveen Pemmaraju, Joie Alvarez, Graciela M. Nogueras‐González, Jing Ning, Ghayas C. Issa, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Guillermo Garcia‐Manero, Hussein A. Abbas

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.29313332

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf

Direct OA link when available
Concepts: Venetoclax, Azacitidine, Myeloid leukemia, Medicine, Refractory (planetary science), Leukemia, Myeloid, Internal medicine, Oncology, Chemistry, Biology, Gene expression, Chronic lymphocytic leukemia, Biochemistry, Gene, DNA methylation, Astrobiology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411285670
doi	https://doi.org/10.1158/1078-0432.29313332
ids.doi	https://doi.org/10.1158/1078-0432.29313332
ids.openalex	https://openalex.org/W4411285670
fwci	0.0
type	preprint
title	Supplementary Figure S1 from Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11215
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9988999962806702
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2720
topics[0].subfield.display_name	Hematology
topics[0].display_name	Chronic Myeloid Leukemia Treatments
topics[1].id	https://openalex.org/T10309
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9988999962806702
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2720
topics[1].subfield.display_name	Hematology
topics[1].display_name	Acute Myeloid Leukemia Research
topics[2].id	https://openalex.org/T11628
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9861000180244446
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2716
topics[2].subfield.display_name	Genetics
topics[2].display_name	Myeloproliferative Neoplasms: Diagnosis and Treatment
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2779675984
concepts[0].level	4
concepts[0].score	0.9168070554733276
concepts[0].wikidata	https://www.wikidata.org/wiki/Q23671272
concepts[0].display_name	Venetoclax
concepts[1].id	https://openalex.org/C2776239401
concepts[1].level	5
concepts[1].score	0.8477131128311157
concepts[1].wikidata	https://www.wikidata.org/wiki/Q416451
concepts[1].display_name	Azacitidine
concepts[2].id	https://openalex.org/C2778729363
concepts[2].level	2
concepts[2].score	0.7108919620513916
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11688946
concepts[2].display_name	Myeloid leukemia
concepts[3].id	https://openalex.org/C71924100
concepts[3].level	0
concepts[3].score	0.5900148749351501
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[3].display_name	Medicine
concepts[4].id	https://openalex.org/C142424586
concepts[4].level	2
concepts[4].score	0.4974241554737091
concepts[4].wikidata	https://www.wikidata.org/wiki/Q7307572
concepts[4].display_name	Refractory (planetary science)
concepts[5].id	https://openalex.org/C2778461978
concepts[5].level	2
concepts[5].score	0.432468056678772
concepts[5].wikidata	https://www.wikidata.org/wiki/Q29496
concepts[5].display_name	Leukemia
concepts[6].id	https://openalex.org/C2779282312
concepts[6].level	2
concepts[6].score	0.42714303731918335
concepts[6].wikidata	https://www.wikidata.org/wiki/Q1956561
concepts[6].display_name	Myeloid
concepts[7].id	https://openalex.org/C126322002
concepts[7].level	1
concepts[7].score	0.35369110107421875
concepts[7].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[7].display_name	Internal medicine
concepts[8].id	https://openalex.org/C143998085
concepts[8].level	1
concepts[8].score	0.33584141731262207
concepts[8].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[8].display_name	Oncology
concepts[9].id	https://openalex.org/C185592680
concepts[9].level	0
concepts[9].score	0.09015962481498718
concepts[9].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[9].display_name	Chemistry
concepts[10].id	https://openalex.org/C86803240
concepts[10].level	0
concepts[10].score	0.08310696482658386
concepts[10].wikidata	https://www.wikidata.org/wiki/Q420
concepts[10].display_name	Biology
concepts[11].id	https://openalex.org/C150194340
concepts[11].level	3
concepts[11].score	0.0
concepts[11].wikidata	https://www.wikidata.org/wiki/Q26972
concepts[11].display_name	Gene expression
concepts[12].id	https://openalex.org/C2777938653
concepts[12].level	3
concepts[12].score	0.0
concepts[12].wikidata	https://www.wikidata.org/wiki/Q1088156
concepts[12].display_name	Chronic lymphocytic leukemia
concepts[13].id	https://openalex.org/C55493867
concepts[13].level	1
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[13].display_name	Biochemistry
concepts[14].id	https://openalex.org/C104317684
concepts[14].level	2
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[14].display_name	Gene
concepts[15].id	https://openalex.org/C190727270
concepts[15].level	4
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q874745
concepts[15].display_name	DNA methylation
concepts[16].id	https://openalex.org/C87355193
concepts[16].level	1
concepts[16].score	0.0
concepts[16].wikidata	https://www.wikidata.org/wiki/Q411
concepts[16].display_name	Astrobiology
keywords[0].id	https://openalex.org/keywords/venetoclax
keywords[0].score	0.9168070554733276
keywords[0].display_name	Venetoclax
keywords[1].id	https://openalex.org/keywords/azacitidine
keywords[1].score	0.8477131128311157
keywords[1].display_name	Azacitidine
keywords[2].id	https://openalex.org/keywords/myeloid-leukemia
keywords[2].score	0.7108919620513916
keywords[2].display_name	Myeloid leukemia
keywords[3].id	https://openalex.org/keywords/medicine
keywords[3].score	0.5900148749351501
keywords[3].display_name	Medicine
keywords[4].id	https://openalex.org/keywords/refractory
keywords[4].score	0.4974241554737091
keywords[4].display_name	Refractory (planetary science)
keywords[5].id	https://openalex.org/keywords/leukemia
keywords[5].score	0.432468056678772
keywords[5].display_name	Leukemia
keywords[6].id	https://openalex.org/keywords/myeloid
keywords[6].score	0.42714303731918335
keywords[6].display_name	Myeloid
keywords[7].id	https://openalex.org/keywords/internal-medicine
keywords[7].score	0.35369110107421875
keywords[7].display_name	Internal medicine
keywords[8].id	https://openalex.org/keywords/oncology
keywords[8].score	0.33584141731262207
keywords[8].display_name	Oncology
keywords[9].id	https://openalex.org/keywords/chemistry
keywords[9].score	0.09015962481498718
keywords[9].display_name	Chemistry
keywords[10].id	https://openalex.org/keywords/biology
keywords[10].score	0.08310696482658386
keywords[10].display_name	Biology
language	en
locations[0].id	doi:10.1158/1078-0432.29313332
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.29313332
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5035605515
authorships[0].author.orcid	https://orcid.org/0000-0001-7103-373X
authorships[0].author.display_name	Naval Daver
authorships[0].author_position	first
authorships[0].raw_author_name	Naval Daver
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5079846889
authorships[1].author.orcid	https://orcid.org/0000-0002-6831-2567
authorships[1].author.display_name	Jayastu Senapati
authorships[1].author_position	middle
authorships[1].raw_author_name	Jayastu Senapati
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5090435894
authorships[2].author.orcid	https://orcid.org/0000-0002-1908-3307
authorships[2].author.display_name	Hagop M. Kantarjian
authorships[2].author_position	middle
authorships[2].raw_author_name	Hagop M. Kantarjian
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5052221681
authorships[3].author.orcid	https://orcid.org/0000-0003-3651-6802
authorships[3].author.display_name	Bofei Wang
authorships[3].author_position	middle
authorships[3].raw_author_name	Bofei Wang
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5034799610
authorships[4].author.orcid	https://orcid.org/0000-0001-8433-3360
authorships[4].author.display_name	Patrick K. Reville
authorships[4].author_position	middle
authorships[4].raw_author_name	Patrick K. Reville
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5056317446
authorships[5].author.orcid	https://orcid.org/0000-0001-8980-3202
authorships[5].author.display_name	Sanam Loghavi
authorships[5].author_position	middle
authorships[5].raw_author_name	Sanam Loghavi
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5050041791
authorships[6].author.orcid	https://orcid.org/0000-0002-4498-4895
authorships[6].author.display_name	Musa Yılmaz
authorships[6].author_position	middle
authorships[6].raw_author_name	Musa Yilmaz
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5010786159
authorships[7].author.orcid	https://orcid.org/0000-0001-9003-0390
authorships[7].author.display_name	Courtney D. DiNardo
authorships[7].author_position	middle
authorships[7].raw_author_name	Courtney D. DiNardo
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5020340537
authorships[8].author.orcid	https://orcid.org/0000-0002-9892-9832
authorships[8].author.display_name	Tapan M. Kadia
authorships[8].author_position	middle
authorships[8].raw_author_name	Tapan M. Kadia
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5078538821
authorships[9].author.orcid	https://orcid.org/0000-0001-7196-9503
authorships[9].author.display_name	Mhd Yousuf Yassouf
authorships[9].author_position	middle
authorships[9].raw_author_name	Mhd Yousuf Yassouf
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5075581944
authorships[10].author.orcid	https://orcid.org/0000-0001-9043-538X
authorships[10].author.display_name	Abhishek Maiti
authorships[10].author_position	middle
authorships[10].raw_author_name	Abhishek Maiti
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5020226783
authorships[11].author.orcid	https://orcid.org/0000-0002-8162-4119
authorships[11].author.display_name	Sankalp Arora
authorships[11].author_position	middle
authorships[11].raw_author_name	Sankalp Arora
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5028081179
authorships[12].author.orcid	https://orcid.org/0000-0002-4533-5176
authorships[12].author.display_name	Guillermo Montalban‐Bravo
authorships[12].author_position	middle
authorships[12].raw_author_name	Guillermo Montalban Bravo
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5055404021
authorships[13].author.orcid	https://orcid.org/0000-0002-9482-4806
authorships[13].author.display_name	Guilin Tang
authorships[13].author_position	middle
authorships[13].raw_author_name	Guilin Tang
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5055045706
authorships[14].author.orcid	https://orcid.org/0000-0001-7679-6453
authorships[14].author.display_name	Gautam Borthakur
authorships[14].author_position	middle
authorships[14].raw_author_name	Gautam Borthakur
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5029750735
authorships[15].author.orcid	https://orcid.org/0000-0002-9140-0610
authorships[15].author.display_name	Koji Sasaki
authorships[15].author_position	middle
authorships[15].raw_author_name	Koji Sasaki
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5088307376
authorships[16].author.orcid	https://orcid.org/0000-0002-1670-6513
authorships[16].author.display_name	Naveen Pemmaraju
authorships[16].author_position	middle
authorships[16].raw_author_name	Naveen Pemmaraju
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5077447981
authorships[17].author.orcid
authorships[17].author.display_name	Joie Alvarez
authorships[17].author_position	middle
authorships[17].raw_author_name	Joie Alvarez
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5018403822
authorships[18].author.orcid	https://orcid.org/0000-0002-6350-2206
authorships[18].author.display_name	Graciela M. Nogueras‐González
authorships[18].author_position	middle
authorships[18].raw_author_name	Graciela M. Nogueras Gonzalez
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5006858509
authorships[19].author.orcid	https://orcid.org/0000-0002-5289-331X
authorships[19].author.display_name	Jing Ning
authorships[19].author_position	middle
authorships[19].raw_author_name	Jing Ning
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5059600583
authorships[20].author.orcid	https://orcid.org/0000-0002-4339-8683
authorships[20].author.display_name	Ghayas C. Issa
authorships[20].author_position	middle
authorships[20].raw_author_name	Ghayas C. Issa
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5022647201
authorships[21].author.orcid	https://orcid.org/0000-0002-9347-2212
authorships[21].author.display_name	Marina Konopleva
authorships[21].author_position	middle
authorships[21].raw_author_name	Marina Konopleva
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5079262854
authorships[22].author.orcid	https://orcid.org/0000-0002-1144-1958
authorships[22].author.display_name	Michael Andreeff
authorships[22].author_position	middle
authorships[22].raw_author_name	Michael Andreeff
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5000750846
authorships[23].author.orcid	https://orcid.org/0000-0002-7621-377X
authorships[23].author.display_name	Farhad Ravandi
authorships[23].author_position	middle
authorships[23].raw_author_name	Farhad Ravandi
authorships[23].is_corresponding	False
authorships[24].author.id	https://openalex.org/A5061026876
authorships[24].author.orcid	https://orcid.org/0000-0002-3631-2482
authorships[24].author.display_name	Guillermo Garcia‐Manero
authorships[24].author_position	middle
authorships[24].raw_author_name	Guillermo Garcia-Manero
authorships[24].is_corresponding	False
authorships[25].author.id	https://openalex.org/A5074807429
authorships[25].author.orcid	https://orcid.org/0000-0003-2946-3562
authorships[25].author.display_name	Hussein A. Abbas
authorships[25].author_position	last
authorships[25].raw_author_name	Hussein A. Abbas
authorships[25].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S1 from Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11215
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9988999962806702
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2720
primary_topic.subfield.display_name	Hematology
primary_topic.display_name	Chronic Myeloid Leukemia Treatments
related_works	https://openalex.org/W4362592484, https://openalex.org/W3048827006, https://openalex.org/W4310159665, https://openalex.org/W4362542584, https://openalex.org/W3131716652, https://openalex.org/W4401878169, https://openalex.org/W2899412336, https://openalex.org/W4401875674, https://openalex.org/W4401979026, https://openalex.org/W4401504076
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.29313332
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.29313332
primary_location.id	doi:10.1158/1078-0432.29313332
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Azacitidine_Venetoclax_and_Magrolimab_in_Newly_Diagnosed_and_Relapsed_Refractory_Acute_Myeloid_Leukemia_Phase_Ib_II_Study_and_Correlative_Analysis/29313332/1/files/55361168.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.29313332
publication_date	2025-06-13
publication_year	2025
referenced_works_count	0
abstract_inverted_index.Treatment	1
abstract_inverted_index.<p>Study	0
abstract_inverted_index.Schema</p>	2
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	26
citation_normalized_percentile.value	0.30445147
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False